UNITY BIOTECHNOLOGY, INC.

Profile

Company Names

UNITY BIOTECHNOLOGY, INC.
CENEXYS, INC.
FORGE INC

Addresses

3280 BAYSHORE BOULEVARD, BRISBANE, CA 94005

1700 OWENS STREET, SUITE 535, SAN FRANCISCO, CA 94158

1471 1/2 HAVENHURST DRIVE, LOS ANGELES, CA 90046

Phone Numbers

(415) 328-5504
(415) 888-3731
(818) 587-4529

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY, OTHER

Year Incorporated:

2009

State Incorporated:

DE

Total Amount Raised:

$208,572,102.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2018-03-15 
$55,049,948.00 
$60,000,000.00 
$4,950,052.00 
Equity 
4
2016-10-14 
$151,230,099.00 
$177,598,051.00 
$26,367,952.00 
Equity 
3
2013-07-03 
$2,041,555.00 
$6,083,265.00 
$4,041,710.00 
Equity 
2
2009-04-23 
$250,000.00 
$1,000,000.00 
$750,000.00 
Debt 
1
2009-04-22 
$500.00 
$500.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GRAHAM 
 
COOPER 
DIRECTOR
JAMIE 
 
DANANBERG 
EXECUTIVE OFFICER
NATHANIEL 
 
DAVID 
EXECUTIVE OFFICER, DIRECTOR
NATHANIEL 
E. 
DAVID 
EXECUTIVE OFFICER, DIRECTOR
TROY 
 
FOSTER 
EXECUTIVE OFFICER
BOB 
 
GOELTZ 
EXECUTIVE OFFICER
KEITH 
 
KLEIN 
EXECUTIVE OFFICER
KEITH 
 
LEONARD 
EXECUTIVE OFFICER, DIRECTOR
DAN 
 
MARQUESS 
EXECUTIVE OFFICER
JOHN 
 
SMITHER 
EXECUTIVE OFFICER
TAMARA 
 
TOMPKINS 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-14 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-03 
D
OTHER 
 
NO REVENUES 
Equity 
2009-04-22 
D
OTHER 
 
NO REVENUES 
Debt 
2009-04-23 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#